-
Mayo Clinic Q&A podcast: Cardiac risks of off-label drugs to treat COVID-19
Share this:
A study published recently in Mayo Clinic Proceedings details information about potential cardiac side effects when using off-label drugs to treat COVID-19. Off-label means the drug has been approved by the Food and Drug Administration to treat a different condition. Some of the off-label drugs being used to treat COVID-19 have a risk of sudden cardiac arrest and death.
On the Mayo Clinic Q&A podcast, Dr. Michael Ackerman, a Mayo Clinic genetic cardiologist and director of the Windland Smith Rice Sudden Death Genomics Laboratory, explains how heart monitoring is important to identify at-risk patients.
Click the player below:
Mayo Clinic Q&A is available on podcast platforms including Apple, Google, Spotify, Stitcher, TuneIn and iHeart.
_________________________________________________
For the latest updates on the COVID-19 pandemic, check the CDC website. For more information and COVID-19 coverage, go to the Mayo Clinic News Network and mayoclinic.org.
Share this:
Related articles
To simplify COVID-19 vaccine administration, the Food and Drug Administration ended the use of the original monovalent COVID-19 vaccines on April 18. People who are due for the bivalent vaccine ...
Like many people throughout the world, Matthew Binnicker, Ph.D., remembers exactly where he was and what he was doing when COVID-19 was classified as a pandemic. ...
While COVID-19 rates in the U.S. are relatively low and are declining, the World Health Organization (WHO) is keeping an eye on a new COVID-19 ...